[HTML][HTML] FDG PET imaging in multiple myeloma: implications for response assessments in clinical trials
S Sundaram, J Driscoll… - American journal of …, 2018 - ncbi.nlm.nih.gov
Abstract 18 F-fluorodeoxyglucose positron emission tomography integrated with computed
tomography (18 F-FDG PET/CT) is an effective modality to assess disease burden, detect …
tomography (18 F-FDG PET/CT) is an effective modality to assess disease burden, detect …
[HTML][HTML] Clinical application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field …
M Nakajo, M Jinguji, S Ito, A Tani, M Hirahara… - Japanese Journal of …, 2024 - Springer
Abstract Machine learning (ML) analyses using 18F-fluorodeoxyglucose (18F-FDG) positron
emission tomography (PET)/computed tomography (CT) radiomics features have been …
emission tomography (PET)/computed tomography (CT) radiomics features have been …
Functional imaging methods for assessment of minimal residual disease in multiple myeloma: current status and novel immunoPET based methods
N Pandit-Taskar - Seminars in hematology, 2018 - Elsevier
Imaging plays a key role in assessment of myeloma. Osteolytic bone lesions are optimally
assessed using structural imaging, however the structural changes lag the functional …
assessed using structural imaging, however the structural changes lag the functional …
[HTML][HTML] Evaluation of an automatic classification algorithm using convolutional neural networks in oncological positron emission tomography
P Pinochet, F Eude, S Becker, V Shah, L Sibille… - Frontiers in …, 2021 - frontiersin.org
Introduction: Our aim was to evaluate the performance in clinical research and in clinical
routine of a research prototype, called positron emission tomography (PET) Assisted …
routine of a research prototype, called positron emission tomography (PET) Assisted …
[HTML][HTML] A whole-body FDG-PET/CT dataset with manually annotated tumor lesions
We describe a publicly available dataset of annotated Positron Emission Tomography/
Computed Tomography (PET/CT) studies. 1014 whole body Fluorodeoxyglucose (FDG) …
Computed Tomography (PET/CT) studies. 1014 whole body Fluorodeoxyglucose (FDG) …
[HTML][HTML] Quantitative imaging and radiomics in multiple myeloma: a potential opportunity?
AS Tagliafico, A Dominietto, L Belgioia, C Campi… - Medicina, 2021 - mdpi.com
Multiple Myeloma (MM) is the second most common type of hematological disease and,
although it is rare among patients under 40 years of age, its incidence rises in elderly …
although it is rare among patients under 40 years of age, its incidence rises in elderly …
[HTML][HTML] Tumor segmentation and feature extraction from whole-body FDG-PET/CT using cascaded 2D and 3D convolutional neural networks
S Jemaa, J Fredrickson, RAD Carano, T Nielsen… - Journal of digital …, 2020 - Springer
Abstract 18 F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) is commonly
used in clinical practice and clinical drug development to identify and quantify metabolically …
used in clinical practice and clinical drug development to identify and quantify metabolically …
[HTML][HTML] Quantitative FDG PET assessment for oncology therapy
K Hirata, N Tamaki - Cancers, 2021 - mdpi.com
Simple Summary PET enables quantitative assessment of tumour biology in vivo.
Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect tumour metabolic activity …
Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect tumour metabolic activity …
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
Multiple myeloma (MM) is a plasma cell malignancy that is characterized by diverse clinical
presentations. Although biochemical assessment of disease activity is commonly used to …
presentations. Although biochemical assessment of disease activity is commonly used to …
New developments in myeloma treatment and response assessment
F Kraeber-Bodéré, B Jamet, D Bezzi… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Recent innovative strategies have dramatically redefined the therapeutic landscape for
treating multiple myeloma patients. In particular, the development and application of …
treating multiple myeloma patients. In particular, the development and application of …